This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
489 °F (NTP, 1992)
255 °C
Chrysene forms crystalline complexes with picric acid (orange-red needles from benzene, melting-point 174-175 °C corrected), s-trinitrobenzene (188.5-189.5 °C corrected) and 2,4,7-trinitrofluorenone (yellow needles from alcohol, melting point 247.8-249 °C)
254 - 256 °C
489 °F
Boiling Point
838 °F at 760 mmHg (NTP, 1992)
448 °C
838 °F
Density
1.274 at 68 °F (NTP, 1992) - Denser than water; will sink
1.274 g/cu cm at 20 °C
1.3 g/cm³
1.274
Physical Description
Chrysene appears as a crystalline solid. Denser than water and insoluble in water. The primary hazard is the threat to the environment. Immediate steps should be taken to limit spread to the environment. Toxic by ingestion. Used to make other chemicals.
Crystals derived from distillation of coal tar; [Hawley]
COLOURLESS-TO-BEIGE CRYSTALS OR POWDER.
Crystalline solid.
Appearance
Red blue fluorescent orthorhombic plates from benzene, acetic acid
Orthorhombic bipyramidal plates from benzene
Colorless platelets with blue fluorescence
State
Solid
Computed Properties
Structural Parameters
Heavy atom count
18
Aromatic heavy atom count
18
Molar refractivity
78.96
TPSA
0.0000
LogP / Solubility
WLOGP
5.15
MLOGP
4.53
XLogP3
5.7
Consensus LogP
5.13
Log S (ESOL)
-5.24
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.15
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-5.42
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-0.46
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
2
Customers Also Viewed
9,10-Di(1-naphthyl)anthracene (purified by sublimation)